Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
- DOI
- 10.1016/j.xjidi.2023.100230
- Published
- 2023-11
- Container
- JID Innovations
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xjidi.2023.100230,
title = {Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream},
author = {Michael D. Howell and Fiona I. Kuo and Beth Rumberger and Erika Boarder and Kang Sun and Kathleen Butler and John E. Harris and Pearl Grimes and David Rosmarin},
year = {2023},
journal = {JID Innovations},
doi = {10.1016/j.xjidi.2023.100230},
url = {https://doi.org/10.1016/j.xjidi.2023.100230}
}RIS
TY - JOUR TI - Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream AU - Michael D. Howell AU - Fiona I. Kuo AU - Beth Rumberger AU - Erika Boarder AU - Kang Sun AU - Kathleen Butler AU - John E. Harris AU - Pearl Grimes AU - David Rosmarin PY - 2023 JO - JID Innovations DO - 10.1016/j.xjidi.2023.100230 UR - https://doi.org/10.1016/j.xjidi.2023.100230 ER -
APA
Howell, M. D., Kuo, F. I., Rumberger, B., Boarder, E., Sun, K., Butler, K., Harris, J. E., Grimes, P., & Rosmarin, D. (2023). Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream. JID Innovations. https://doi.org/10.1016/j.xjidi.2023.100230
Source records
- crossref · retrieved 2026-09-27T00:36:49.582Z